Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Washington University School of Medicine
OHSU Knight Cancer Institute
Prelude Therapeutics
Case Comprehensive Cancer Center
Stanford University
Masonic Cancer Center, University of Minnesota
Yale University
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rutgers, The State University of New Jersey
CASI Pharmaceuticals, Inc.